James Fingleton

Senior Clinical Lecturer

University of Otago

New Zealand

Research Interests

Explore related searches

Professors in New Zealand

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Fingleton is a Senior Clinical Lecturer at the University of Otago, Wellington, New Zealand. His research primarily focuses on asthma management and chronic obstructive pulmonary disease (COPD), with recent articles addressing treatable traits in asthma, environmental impacts of inhaled medicines, and novel intervention strategies for reducing reliever reliance. He has also investigated the implications of biologics in severe asthma and guidelines for adolescent and adult asthma care.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (18)

Richard Beasley

Medical Research Institute of New Zealand

NEW ZEALAND

James Fingleton

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Treatable Trait Guided Asthma Management: A Feasibility Study

Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement

Review of the New Zealand Asthma and Respiratory Foundation’s New Zealand Adolescent and Adult Asthma guidelines

Evaluating the Feasibility of a Community Pharmacy-Delivered Behaviour Change Intervention to Reduce Reliever Reliance in Asthma

Real-world biologics response and super-response in the International Severe Asthma Registry cohort.

Prevention of Re-Hospitalization for Acute Exacerbations: Perspectives of People with Chronic Obstructive Pulmonary Disease: A Qualitative Study

Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention

Prevention of Re-Hospitalization for Acute Exacerbations: Perspectives of People with Chronic Obstructive Pulmonary Disease: A Qualitative Study.

Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis

Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials

Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.

Rhinothermy delivered by nasal high flow therapy in the treatment of the common cold: a randomised controlled trial

ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis

Engaging Māori with qualitative healthcare research using an animated comic.

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

Collaborators (18)

Richard Beasley

Peter Gibson

Karen Oldfield

Christina Baggott

Nethmi Kearns

Sinthia Bosnic-Anticevich

Irene Braithwaite

Mark Weatherall

Kebede Beyene

William Levack

Tristram Richard Ingham

Jo Hardy

Jeff Harrison

Lee Hatter

Bernadette Huatau Jones

Matthew Peters

Nick Shortt

Patrick Mitchell

Make your next move.